Filing search / ALX Oncology Holdings Inc. / "Independent" / Page 2

S-8

1af30a unlmlz9onvi

7 Mar 24

Registration of securities for employees

7:56pm

S-8

EX-23.1

h97cw1y8kwg19wmo6u4i

7 Mar 24

Registration of securities for employees

7:56pm

8-K

EX-1.1

0nnbh fdox12s

6 Oct 23

ALX Oncology Announces Pricing of Public Offering

6:06am

424B5

uhoep

6 Oct 23

Prospectus supplement for primary offering

6:05am

8-K

ykc 8zj3po

4 Oct 23

Results of Operations and Financial Condition

5:21pm

424B5

mmx3i4rt265o8kcjx6vn

4 Oct 23

Prospectus supplement for primary offering

5:21pm

424B3

x7zi83jtuu9wl6btu

8 Sep 23

Prospectus supplement

4:25pm

8-K

EX-3.1

wki2fn

20 Jun 23

Amendments to Articles of Incorporation or Bylaws

8:45am

8-K

u3irvaxvl 72jvm

20 Jun 23

Amendments to Articles of Incorporation or Bylaws

8:45am

8-K

EX-10.1

hp6 mpqaovg

31 Oct 22

ALX Oncology Enters $100 Million Loan Facility Agreement with Oxford Finance and Silicon Valley Bank to Support Ongoing Development of Evorpacept

7:30am